Drug profile · INN
oxytetracycline hydrochloride
TERRAMYCIN W/ POLYMYXIN
oxytetracycline hydrochloride (TERRAMYCIN W/ POLYMYXIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — oxytetracycline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
oxytetracycline hydrochloride (TERRAMYCIN W/ POLYMYXIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is oxytetracycline hydrochloride?
oxytetracycline hydrochloride (TERRAMYCIN W/ POLYMYXIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxytetracycline hydrochloride?
TERRAMYCIN W/ POLYMYXIN is a marketed brand name for oxytetracycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxytetracycline hydrochloride?
oxytetracycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.